GeneLink's Sales Rise 17 Percent in Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – GeneLink today reported that its third-quarter revenues increased nearly 17 percent to $2.1 million from $1.8 million for the third quarter of 2008, with nearly all of its sales coming from its GeneWize nutritional and dermatological genetic testing services.

GeneLink posted a net loss of $784,000 for the quarter ended Sept. 30, an increase of 53 percent over its net loss of $514,000 for third quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.